The global coronary artery bypass graft market size was valued at USD 77.3 million in 2016 and is expected to grow with a CAGR of 5.8% during the forecast period. Rise in prevalence of cardiovascular diseases such as Coronary Artery Disease (CAD) or Coronary Heart disease (CHD), Myocardial Infarction (MI), hypertension, and peripheral vascular disease, and introduction of technologically advanced products are the key drivers expected to nurture market growth worldwide.
Sedentary lifestyle, mental stress, and consumption of junk food are the key reasons for developing Cardiovascular Diseases (CVDs) in individuals around the globe. According to the World Health Organization, CVDs contribute to the maximum number of deaths globally. In 2012, nearly 17.5 million deaths were reported due to CVDs, representing 31.0% of the global death statistics. Out of the 17.5 million deaths reported, 7.4 million were owing to CHD, and 6.7 million were due to stroke. The number of deaths is anticipated to reach over 23.6 million by 2030.
U.S. coronary artery bypass graft (CABG) market, by type, 2014 - 2025 (USD Million)
Globally growing geriatric population is anticipated tobe a vital driver to increase coronary artery bypass graft surgeries and expected to bolster the growth of this vertical over the forecast period. According to the American Heart Association (AHA) estimates, the global geriatric population is anticipated to account for approximately 20.0% of the total population by 2030. In addition, as per the statistics published by the AHA, in 2012, the number of CABG surgeries performed in the U.S. were 519,000, out of which 371,000 were performed on men and 148,000 on women. In addition, the estimates state that the number of CABG surgeries performed worldwide are more than 800,000 every year.Introduction of technologically advanced products such as Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) or keyhole, Anastomosis Assist Devices (AAD), and Endoscopic Vessel Harvesting (EVH) devices are expected to propel the demand for CABG surgeries over the forecast period. MIDCAB is a less invasive method of CABG, which gains surgical access to the heart with a smaller incision. MIDCAB is off-pump technology and performed without using the heart-lung machine. MIDCAB offers benefits such as faster recovery from the disease, low bleeding & blood trauma, lower infection rate, and affordable surgery cost.
The key type segments analyzed into market are saphenous vein grafts, internal thoracic artery grafts, and other graft. Saphenous vein graft segment dominated the industry in 2016 and is expected to witness lucrative growth over the forecast period. Increasing preference for the Saphenous Vein Graft (SVG) over other vein grafts owing to various advantages such as being longer in length, ease in handling, and less transfusion requirement have supported the market growth.
The other graft segment is further segmented into radial artery and gastroepiploic artery. The Right Gastroepiploic Artery (RGEA) is a suitable and an alternative conduit for coronary bypass surgery and is specifically used in patients who do not have appropriate saphenous veins to harvest for grafts.
Surgical Procedure Insights
The surgical procedure segment includes single, double, triple, and quadrupole CABG surgeries. The triple bypass surgeries segment is expected to dominate this industry during the forecast period owing to the rising prevalence of CVDs such as CAD or CHD, MI, or strokes across the globe.
The number of double bypass surgeries are common and performed largely worldwide, hence the segment is expected to be fastest and register a high CAGR comparatively, over the forecast period.
The on-pump CABG segment emerged as the largest segment in 2016. Rising preference for on-pump CABG procedures from cardiothoracic surgeons or cardiac surgeons coupled with the rising use of heart-lung machines, oxygenators, positioners, and stabilizers has assisted in the market growth.
The off-pump CABG segment is expected to gain market share over the forecast period. New techniques such as Totally Endoscopic Robotically Assisted Coronary Artery Bypass (TECAB) grafting are expected to support this vertical’s growth.
Global CABG market, by technology, 2016 (USD Million)
The conventional vessel harvesting segment is expected to dominate the market during the forecast period due to its higher usage in coronary artery bypass graft procedures. However, the segment is anticipated to lose market share in the near future owing to the emergence of endoscopic vessel harvesting technique, as it minimizes scarring, morbidity, and infections associated with traditional longitudinal incisions resulting in providing improved outcomes.
The EVH segment is expected to gain the market share over the forecast period as it eliminates the requirement for long incisions associated with open (conventional) harvesting, resulting in reducing the risk of wound infection and other complications, minimizing postoperative pain, and increasing patient satisfaction level.
North America held around 56.9% share in the CABG market in 2016 owing to increasing prevalence of CVDs, presence of target population, and changing lifestyle of individuals in the U.S. and Canada.
Asia Pacific also held a substantial market share in 2016 due to rising number of CABG surgeries in India & Japan coupled with growing population, and increasing patient awareness about the diseases. Europe is anticipated to register a high CAGR comparatively over the forecast period, owing to the large number of CABG surgeries being performed in the region.
Some of the major players competing in this space includeMedtronic; TERUMO CORPORATION; Guidant Group; MAQUET Holding B.V. & Co.KG; Vitalitec International, Inc.; Novadaq Technologies Inc.; KARL STORZ GmbH & Co. KG; Edwards Lifesciences; Genesee Biomedical Inc.; and Sorin Group. These players are focusing on growth strategies such as product launch, acquisition & merger, and regional expansion.
For instance, in October 2016, KARL STORZ GmbH & Co. KG launched new endoscopic near-infrared (NIR)/indocyanine green (ICG) fluorescence imaging system used in minimally invasive surgery that enhances visual assessment of vessels, blood flow, and related tissue perfusion.
Base year for estimation
Actual estimates/Historic data
2014 - 2015
2017 - 2025
Revenue in USD Million & CAGR from 2017 to 2025
North America, Europe, Asia Pacific, Latin America & MEA
U.S., Canada, UK, Germany, Japan, China, Brazil, Mexico, & South Africa
Revenue, competitive landscape, growth factors, and trends
15% free customization scope (equivalent to 5 analysts working days)
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization
Segments Covered in the Report
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research, Inc. has segmented the CABG market on the basis of type, surgical procedure, technology, technique, and region:
Type Outlook (Revenue, USD Million, 2014 - 2025)
Saphenous Vein Grafts
Internal Thoracic Artery Grafts
Surgical Procedure Outlook (Revenue, USD Million, 2014 - 2025)
Single CABG Surgery
Double CABG Surgery
Triple CABG Surgery
Quadruple CABG Surgery
Technology Outlook (Revenue, USD Million, 2014 - 2025)
Technique Outlook (Revenue, USD Million, 2014 - 2025)
Conventional Vessel Harvesting
Endoscopic Vessel Harvesting
Regional Outlook (Revenue, USD Million, 2014 - 2025)
Middle East and Africa (MEA)
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.